AP690A - Immunomodulators based on a polypeptide other than human interleukin 10. - Google Patents

Immunomodulators based on a polypeptide other than human interleukin 10. Download PDF

Info

Publication number
AP690A
AP690A APAP/P/1997/000962A AP9700962A AP690A AP 690 A AP690 A AP 690A AP 9700962 A AP9700962 A AP 9700962A AP 690 A AP690 A AP 690A
Authority
AP
ARIPO
Prior art keywords
met
seq
human
thr
lys
Prior art date
Application number
APAP/P/1997/000962A
Other languages
English (en)
Other versions
AP9700962A0 (en
Inventor
Christian Gronhoj Larsen
Borbala Gesser
Original Assignee
Steeno Res Group A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group A/S filed Critical Steeno Res Group A/S
Publication of AP9700962A0 publication Critical patent/AP9700962A0/xx
Application granted granted Critical
Publication of AP690A publication Critical patent/AP690A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
APAP/P/1997/000962A 1994-07-05 1995-06-07 Immunomodulators based on a polypeptide other than human interleukin 10. AP690A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05

Publications (2)

Publication Number Publication Date
AP9700962A0 AP9700962A0 (en) 1997-04-30
AP690A true AP690A (en) 1998-10-16

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/000962A AP690A (en) 1994-07-05 1995-06-07 Immunomodulators based on a polypeptide other than human interleukin 10.

Country Status (27)

Country Link
US (3) US6159937A (ro)
EP (2) EP1013764A1 (ro)
JP (1) JPH10502249A (ro)
CN (1) CN1216992C (ro)
AP (1) AP690A (ro)
AT (1) ATE195003T1 (ro)
AU (1) AU686816B2 (ro)
BR (1) BR9508243A (ro)
CA (1) CA2194444C (ro)
CZ (1) CZ1497A3 (ro)
DE (1) DE69518156T2 (ro)
DK (1) DK0769054T3 (ro)
EE (1) EE03451B1 (ro)
ES (1) ES2148525T3 (ro)
FI (1) FI970009L (ro)
GR (1) GR3034628T3 (ro)
HU (1) HU220344B (ro)
MX (1) MX9606537A (ro)
NO (1) NO970020L (ro)
NZ (1) NZ287406A (ro)
PL (1) PL181042B1 (ro)
PT (1) PT769054E (ro)
RO (1) RO118758B1 (ro)
RU (1) RU2218348C2 (ro)
SK (1) SK283096B6 (ro)
UA (1) UA57702C2 (ro)
WO (1) WO1996001318A1 (ro)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
JP2000509073A (ja) * 1996-05-02 2000-07-18 シェーリング コーポレイション 虚血再灌流傷害の治療または予防の方法
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
AU9449398A (en) * 1997-10-10 1999-05-03 Imperial College Innovations Ltd. Use of csaidtm compounds for the management of uterine contractions
US6685931B1 (en) * 1998-12-22 2004-02-03 Schering Corporation Treatment of hepatitis C virus infections with interleukin-10
AU5155700A (en) * 1999-05-25 2000-12-12 Canji, Inc. Gene therapy of pulmonary disease
JP3871503B2 (ja) * 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
CA2429769C (en) * 2000-12-07 2016-04-26 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
CA2474360A1 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
EP1490101A4 (en) * 2002-03-05 2006-09-20 Univ Texas PROCESS FOR IMPROVING IMMUNE INDUCTION WITH MDA-7
RU2218347C2 (ru) * 2002-09-17 2003-12-10 Энтофарм Ко. Лтд Способ получения тридекапептида и пентапептид для его получения
RU2222543C2 (ru) * 2002-09-17 2004-01-27 Энтофарм Ко. Лтд. Способ получения тридекапептида
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
WO2004103294A2 (en) * 2003-05-15 2004-12-02 Tanox, Inc. Methods and compositions for the prevention and treatment of sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
US8034790B2 (en) * 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
WO2005087793A2 (en) 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
CU23472A1 (es) * 2004-09-17 2009-12-17 Ct Ingenieria Genetica Biotech Péptido antagonista de la interleucina-15
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
CA2597329C (en) * 2005-02-08 2016-10-11 Board Of Regents, The University Of Texas System Compositions and methods involving mda-7 for the treatment of cancer
US20100028296A1 (en) * 2005-05-02 2010-02-04 Chavez Raymond A Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
DK2816118T3 (en) 2005-05-31 2018-12-03 Univ Colorado Regents Methods for delivery of genes
EP2041576B1 (en) * 2006-06-21 2011-08-10 Apogenix GmbH Differential cytokine expression in human cancer
AU2007271349A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human IL-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
WO2011047097A2 (en) * 2009-10-13 2011-04-21 Sigalov Alexander B Inhibition of trem receptor signaling with peptide variants
WO2012122985A1 (en) * 2011-03-14 2012-09-20 University Of Copenhagen Antagonists of the interleukin- 1 receptor
PT2814843T (pt) 2012-02-13 2020-06-18 Agency Science Tech & Res Anticorpos monoclonais humanos neutralizantes de il-b
DK3369435T3 (da) 2013-07-18 2019-11-25 Xalud Therapeutics Inc Sammensætning til behandling af inflammatorisk ledsygdom
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
EP3551034A1 (en) 2016-12-07 2019-10-16 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
CA3054156A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
WO2020106757A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
JP7315968B2 (ja) * 2019-01-31 2023-07-27 積水メディカル株式会社 生物学的試料中の遊離ａｉｍの免疫学的分析方法及び対象におけるｎａｓｈの検出方法
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000349A1 (en) * 1989-06-28 1991-01-10 Schering Corporation Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT600970E (pt) * 1991-08-06 2000-05-31 Schering Corp Utilizacao de analogos ou antagonistas da interleucina-10 para tratar toxicidade induzida por endotoxinas ou superantigenios
CA2131524A1 (en) * 1992-03-04 1993-09-16 Maria-Grazia Roncarolo Use of interleukin-10 to suppress graft-vs.-host disease
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
WO1994004180A2 (en) * 1992-08-20 1994-03-03 Schering Corporation Novel uses of il-4 and/or il-10, and antibodies against the same
IL110413A0 (en) * 1993-07-26 1994-10-21 Schering Corp Agonists and antagonists of human interleukin-10

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000349A1 (en) * 1989-06-28 1991-01-10 Schering Corporation Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same

Also Published As

Publication number Publication date
AU2612195A (en) 1996-01-25
FI970009A7 (fi) 1997-03-04
EP0769054B1 (en) 2000-07-26
DE69518156T2 (de) 2001-01-11
HUT76673A (en) 1997-10-28
CN1159830A (zh) 1997-09-17
WO1996001318A1 (en) 1996-01-18
PL319429A1 (en) 1997-08-04
CA2194444C (en) 2003-01-14
DE69518156D1 (de) 2000-08-31
NO970020D0 (no) 1997-01-03
CN1216992C (zh) 2005-08-31
GR3034628T3 (en) 2001-01-31
MX9606537A (es) 1997-12-31
RU2218348C2 (ru) 2003-12-10
RO118758B1 (ro) 2003-10-30
EE03451B1 (et) 2001-06-15
ATE195003T1 (de) 2000-08-15
JPH10502249A (ja) 1998-03-03
CA2194444A1 (en) 1996-01-18
HU9603615D0 (en) 1997-02-28
CZ1497A3 (en) 1997-05-14
NZ287406A (en) 1998-07-28
PT769054E (pt) 2000-11-30
EP1013764A1 (en) 2000-06-28
AU686816B2 (en) 1998-02-12
ES2148525T3 (es) 2000-10-16
UA57702C2 (uk) 2003-07-15
HU220344B (hu) 2001-12-28
US6159937A (en) 2000-12-12
EE9700029A (et) 1997-08-15
DK0769054T3 (da) 2000-11-13
AP9700962A0 (en) 1997-04-30
EP0769054A1 (en) 1997-04-23
NO970020L (no) 1997-03-05
SK161496A3 (en) 1997-08-06
US6168791B1 (en) 2001-01-02
US6599501B1 (en) 2003-07-29
FI970009A0 (fi) 1997-01-02
BR9508243A (pt) 1997-10-21
FI970009L (fi) 1997-03-04
HK1012416A1 (en) 1999-07-30
SK283096B6 (sk) 2003-02-04
PL181042B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
US6168791B1 (en) Antibodies that bind immunomodulators
AP883A (en) Synthetic IL-10 analogues.
US6451308B1 (en) Antagonists of interleukin-15
ES2612383T3 (es) WSX-1/IL-27 como una diana para respuestas antiinflamatorias
JP3683291B2 (ja) インターロイキン１２のｐ４０サブユニットを含んでなる医薬
US10227382B2 (en) Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
JP2009536170A (ja) 治療用の抗体標的指向サイトカイン
HU216310B (hu) Eljárás citokinszintézis inhibitorfaktor (CSIF), CSIF-aktivitású polipeptidek és CSIF-antagonisták, valamint ezeket tartalmazó gyógyszerkészítmények előállítására
US20230338473A1 (en) Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokinerelease syndrome and cytokine storm associated disorders
HK1012416B (en) Immunomodulators
Boger et al. Immunomodulatory approaches to the treatment of inflammation
MXPA98005648A (en) Synthetic il-10 analogues
Dy Interleukin 3 (IL-3) and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Production by Normal and Tumor Cells: Effect on Hematopoietic Cell Histamine Synthesis
AU2006246489A1 (en) Compositions and methods for achieving immune suppression